- Glaxo Wellcome's appointments for its operations in Asia Pacific are: (ex-Glaxo) Alan Barker area director, southeast Asia; David Pierce area director, northeast Asia; Ken Windle area director, Australia and New Zealand; and (ex-Wellcome) Chris Howarth area director, Indian subcontinent; and Ho Sau-On chief executive of the Hazeline cosmetics business. Meantime, former head of Wellcome Japan, Gabrial Cipau, has resigned after Glaxo's Christopher Adam was appointed to oversee the meger of the Japanese operations.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze